Weight-loss injections such as GLP-1 receptor agonists (including semaglutide and tirzepatide) have transformed obesity ...

A new daily pill could offer a major breakthrough for people living with type 2 diabetes and struggling with weight management ...

Industry estimates indicate that widely used drugs such as Ozempic and Wegovy, both based on the active ingredient semaglutide, will begin facing generic competition this year.

A new pill could help patients lose more weight and gain better control of their blood sugar levels than current weight loss medications, a promising new study has found.

Ahmedabad: Zydus Lifesciences Limited said it plans to launch semaglutide injection in India under the brand names Semaglyn, Mashema and Alterme after.

Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

aInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA bSchool of Medicine, University of Washington, Seattle, WA, USA cGeneral Medicine Service, Department of ...

The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to ...

Here’s something big: scientists in China have actually reversed type 2 diabetes using stem-cell therapy. It’s a major step ...

Zydus plans to launch its diabetes and obesity injection using a reusable adjustable pen device after patent expiry, as more Indian drugmakers enter the market.

Zydus to launch Semaglutide Injection in India, featuring a unique reusable pen for improved diabetes and obesity management.

Abstract: Diabetes mellitus is a global health crisis characterized by poor blood sugar regulation, impacting millions of people worldwide and leading to severe complications and mortality. Although ...